Form 4 for IBO IMPACT BIOMEDICAL INC.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-12 · accession 0001493152-24-047410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-11-22 | 2024-11-12+ | IBO | DSS, INC. | 10% | S - Sale | $2.99 | -5,700 | 58.3K | -9% | -$17.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-13 | S | D | 200 | $2.80 | 58,100 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
| 2 | Common | Common Stock | 2024-11-18 | S | D | 5,000 | $3.02 | 53,100 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
| 3 | Common | Common Stock | 2024-11-12 | S | D | 500 | $2.76 | 58,300 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |